(93) argued that IL-6 could promote the development of liver cancer by recruiting immunosuppressive cells and excluding CD8+ T cells in tumor microenvironments, and that IL-6 may also damage the function of infiltrated T cells in tumor tissues, thus inhibiting antitumor immunity. The gene discussed is CD8A; the disease is neoplasm.